Horizon Pharma | HZNP - Należności Handlowe



Należności Handlowe Zmiana Data
AbbVie USD 12.77B 132M 2025-09
ALKERMES USD 334.02M 21.08M 2025-12
Amgen USD 9.57B 1.08B 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
Bausch Health Companies USD 2.35B 66M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Cara Therapeutics USD 2.24M 2.26M 2025-03
Coherus Biosciences USD 62.44M 59.9M 2025-03
Eli Lilly USD 19.46B 2.25B 2025-09
Merck USD 12.12B 596M 2025-09
Novartis USD 8.98B 192M 2025-09
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
Prestige Brands USD 190.46M 8.54M 2025-12
Supernus Pharmaceuticals USD 187.8M 16.55M 2025-12
Takeda JPY 757.92B 55.68B 2025-12
Xeris Pharmaceuticals USD 53.75M 700K 2025-09
Zoetis USD 1.59B 49M 2025-12